Atlas Trials

Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma

Clinical trial NCT00691236 · UNKNOWN

Trial details

NCT number
NCT00691236
Sponsor
Tata Memorial Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Osteosarcoma
Start date
2008-05-01
Primary completion
2013-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.